Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review

Liang, B; Huang, T; Kuang, SL; Xie, GY; Liu, TQ; Chen, YY

Chen, YY (通讯作者)，Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Hepatobiliary Pancreat & Spleen Surg, Nanning, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Introduction: Although surgery is the preferred treatment for sarcomatoid hepatocellular carcinoma (SHC), the prognosis remains considerably poor due ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索